Plain-English translation of NCT05570227 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Melanoma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand how melanoma tumors use energy and nutrients to grow. Some participants will receive an intravenous infusion of a labeled glucose (a type of sugar) before their tumor is surgically removed or biopsied. This special glucose helps researchers track how the tumor uses energy. All participants will have tumor tissue and blood samples collected for analysis.
Not all melanoma patients respond the same way to treatment. By understanding how individual tumors use energy at the metabolic level, researchers hope to predict which patients will benefit from which treatments and ultimately improve outcomes.
You likely qualify if…
You likely don't qualify if…
If you are in the glucose infusion group, you will receive an intravenous infusion of labeled glucose for about 2–3 hours before your tumor surgery or biopsy. Blood samples will be taken during and after the infusion to track the glucose. At the time of your procedure, tumor tissue will be collected and frozen for analysis. All participants will have blood and tissue samples studied to understand metabolism and tumor characteristics. The study is based at a single center in Australia.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Australia
Sponsor
Peter MacCallum Cancer Centre, Australia
Enrollment target
~240 participants
Started
June 2023
Primary completion
October 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Aparna Rao
Peter MacCallum Cancer Centre, Australia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.